In APS, the complement system is activated either with C5b-initiated formation of a membrane attack complex, which triggers proinflammatory signaling pathways and, through binding C5a with endothelial cells, increased neutrophil adhesion, expression of tissue factors, and release of other procoagulant agents [64,67]. The gene discussed is C5; the disease is autoimmune polyendocrinopathy.